Announcement on Implementation of Dividend Distribution for 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Implementation of Dividend Distribution for 2025
Filed with SSE · · 4 pages · Chinese
Release
Xiamen Amoytop Biotech Co., Ltd. on 6ix
Earlier from Xiamen Amoytop Biotech
- Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders Without Sales Restrictions Concerning Share Repurchase
- Announcement on Resolutions of the 20th Meeting of the 9th Board of Directors
- Announcement on Progress and Implementation Result of Shares Repurchase and Share Changes
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
- Indicative Announcement on Reply to Review and Inquiry Letter of Issuance of Convertible Corporate Bonds by the Company to Non-specific Objects and Update of Application Documents such as Prospectus
Later from Xiamen Amoytop Biotech
- Announcement on Application for Issuance of Convertible Corporate Bonds to Non-specific Objects Approved by the Listing Review Committee of Shanghai Stock Exchange
- Announcement on Adjusting Upper Limit of Share Repurchase Price after Implementation of Dividend Distribution for 2025
- Announcement on Initially Repurchasing Shares through Call Auction and Progress in Repurchasing
- Announcement on Repurchasing 1% Shares through Call Auction and Progress in Repurchasing Shares
- Announcement on Voluntary Disclosure on the Acceptance Notification of Clinical Trial Application for ACT201 Injection
Follow Xiamen Amoytop Biotech into a list and get an email when it puts out news.
Follow Xiamen Amoytop Biotech